AIFA. Lists of Pharmaceutical Representatives for the year 2016

Fedaisf editorial staff

December 15, 2016

Starting from 2017, a new system will be implemented which will allow Pharmaceutical Companies to send, pursuant to art. 122, paragraph 1, of Legislative Decree lgs. 219/2006, of the lists of Scientific Representatives of the drug by direct insertion in the new one Front End of AIFA.

For the transmission of data relating to 2016, taking into account the exceptional nature of this phase of implementation of the new information systems of the Agency, an extension of the deadlines for the presentation of the aforementioned lists will be envisaged.

Una nuova comunicazione dell’Ufficio Informazione Scientifica – che sarà verosimilmente pubblicato sul portale istituzionale intorno alla metà del prossimo mese di gennaio – definirà con esattezza i termini della proroga e fornirà le istruzioni per le nuove modalità di inserimento dei dati degli Informatori Scientifici sul Front End.

Therefore, before proceeding to comply with the aforementioned legal obligation, the Companies are invited to wait for the subsequent communication from the undersigned Office, bearing in mind that the postal address DATA_informatori@aifa.mailcert.it it will no longer be usable.

AIFA – Avviso alle Aziende Farmaceutiche – 14/12/2016